Antihypertensive therapy in patients with pre-eclampsia: A prospective randomised multicentre study comparing dihydralazine with urapidil
Authors:
- Juergen R. WackerJuergen R. Wacker
- Barbara K. WagnerBWBarbara K. Wagner
- Volker BrieseVBVolker Briese
- Burkhard SchaufBSBurkhard Schauf
- Lothar HeilmannLHLothar Heilmann
- Clemens BartzCBClemens Bartz
- Hartmut HoppHHHartmut Hopp
- 1 August 2006
- journal article
- research article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 127 (2) , 160-165
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Hydralazine for treatment of severe hypertension in pregnancy: meta-analysisBMJ, 2003
- Hypertension Therapy During PregnancyClinical Obstetrics and Gynecology, 2002
- Nifedipine or hydralazine as a first‐line agent to control hypertension in severe preeclampsiaActa Obstetricia et Gynecologica Scandinavica, 2002
- Antihypertensive drugs during pregnancySeminars in Perinatology, 2001
- Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in PregnancyAmerican Journal of Obstetrics and Gynecology, 2000
- Management of hypertension in pregnancyBMJ, 1999
- Prevention of preeclampsia: A big disappointmentAmerican Journal of Obstetrics and Gynecology, 1998
- UrapidilDrugs, 1998
- A Randomized Controlled Pilot Study Comparing Urapidil to Dihydralazine in the Management of Severe Hypertension in PregnancyHypertension in Pregnancy, 1997
- Pharmacodynamics and pharmacokinetics of urapidil in hypertensive patients: A crossover study comparing infusion with an infusion-capsule combinationEuropean Journal of Clinical Pharmacology, 1987